As American public company second quarter results trickled in last week, Cresco Labs joined Trulieve, Green Thumb Industries, and Curaleaf among the ranks of “profitable”, as measured by quarterly Earnings Before Interest and Taxes (EBIT). A common thread also runs through all the profitable public companies, as each reports quarterly revenues around $100 million, with Cresco Labs at $94m, Green Thumb Industries at $120m, Curaleaf at $117m, and Trulieve at $121m. 

MedMen had not reported their second quarter as of publication.


Editor Mike is an itinerate reporter, recovering political consultant, and strategy game devotee.